Betamethasone disodium phosphate/chloramphenicol/colistimethate sodium/tetracycline
Latest Information Update: 29 Sep 2016
At a glance
- Originator SIFI
- Class Anti-inflammatories; Antibacterials; Chloramphenicols; Eye disorder therapies; Polymixins; Pregnadienetriols; Tetracyclines
- Mechanism of Action Cell membrane structure inhibitors; Glucocorticoid receptor agonists; Peptidyltransferase inhibitors; Protein 30S ribosomal subunit inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Eye disorders